Rockwell Medical, Inc. (RMTI)
RMTI Stock Price Chart
Explore Rockwell Medical, Inc. interactive price chart. Choose custom timeframes to analyze RMTI price movements and trends.
RMTI Company Profile
Discover essential business fundamentals and corporate details for Rockwell Medical, Inc. (RMTI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
27 Jan 1998
Employees
244.00
Website
https://www.rockwellmed.comCEO
Mark Strobeck
Description
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
RMTI Financial Timeline
Browse a chronological timeline of Rockwell Medical, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.04, while revenue estimate is $16.24M.
Earnings released on 14 Aug 2025
EPS came in at -$0.05 matching the estimated -$0.05, while revenue for the quarter reached $16.07M , missing expectations by -1.60%.
Earnings released on 12 May 2025
EPS came in at -$0.04 falling short of the estimated -$0.03 by -33.33%, while revenue for the quarter reached $18.91M , beating expectations by +8.33%.
Earnings released on 20 Mar 2025
EPS came in at -$0.02 falling short of the estimated $0.02 by -200.00%, while revenue for the quarter reached $24.67M , beating expectations by +28.98%.
Earnings released on 12 Nov 2024
EPS came in at $0.05 surpassing the estimated $0.01 by +400.00%, while revenue for the quarter reached $28.32M , beating expectations by +6.85%.
Earnings released on 8 Aug 2024
EPS came in at $0.01 surpassing the estimated $0.00 by +125.73%, while revenue for the quarter reached $25.83M , beating expectations by +11.20%.
Earnings released on 14 May 2024
EPS came in at -$0.02 surpassing the estimated -$0.05 by +60.00%, while revenue for the quarter reached $22.68M , beating expectations by +4.50%.
Earnings released on 21 Mar 2024
EPS came in at $0.02 surpassing the estimated -$0.08 by +125.00%, while revenue for the quarter reached $22.09M , missing expectations by -2.37%.
Earnings released on 14 Nov 2023
EPS came in at -$0.07 surpassing the estimated -$0.12 by +41.67%, while revenue for the quarter reached $23.77M , beating expectations by +5.04%.
Earnings released on 14 Aug 2023
EPS came in at -$0.18 falling short of the estimated -$0.12 by -50.00%, while revenue for the quarter reached $18.08M , meeting expectations.
Earnings released on 15 May 2023
EPS came in at -$0.10 surpassing the estimated -$0.18 by +44.44%, while revenue for the quarter reached $19.67M , beating expectations by +2.87%.
Earnings released on 30 Mar 2023
EPS came in at -$0.20 surpassing the estimated -$0.39 by +48.72%, while revenue for the quarter reached $19.31M , beating expectations by +18.41%.
Earnings released on 14 Nov 2022
EPS came in at -$0.40 falling short of the estimated -$0.37 by -8.11%, while revenue for the quarter reached $18.69M , missing expectations by -3.50%.
Earnings released on 15 Aug 2022
EPS came in at -$0.56 surpassing the estimated -$0.88 by +36.36%, while revenue for the quarter reached $18.68M , beating expectations by +11.20%.
Earnings released on 16 May 2022
EPS came in at -$0.84 surpassing the estimated -$0.99 by +15.15%, while revenue for the quarter reached $16.12M , missing expectations by -14.23%.
Stock split effective on 13 May 2022
Shares were split 1 : 11 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Apr 2022
EPS came in at -$0.09 surpassing the estimated -$0.99 by +90.91%, while revenue for the quarter reached $15.33M , missing expectations by -13.14%.
Earnings released on 15 Nov 2021
EPS came in at -$0.88 falling short of the estimated -$0.77 by -14.29%, while revenue for the quarter reached $15.99M , missing expectations by -26.29%.
Earnings released on 16 Aug 2021
EPS came in at -$0.99 falling short of the estimated -$0.88 by -12.50%, while revenue for the quarter reached $15.14M , missing expectations by -16.74%.
Earnings released on 17 May 2021
EPS came in at -$0.88 surpassing the estimated -$0.99 by +11.11%, while revenue for the quarter reached $15.47M , missing expectations by -10.00%.
Earnings released on 31 Mar 2021
EPS came in at -$0.99 falling short of the estimated -$0.88 by -12.50%, while revenue for the quarter reached $15.16M .
Earnings released on 9 Nov 2020
EPS came in at -$1.10 falling short of the estimated -$0.77 by -42.86%, while revenue for the quarter reached $15.28M , meeting expectations.
RMTI Stock Performance
Access detailed RMTI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.